TRIM27 suppresses inflammation injuries in pediatric pneumonia by targeting TLR4/NF-κB signaling pathway
Main Article Content
Keywords
tri-domain protein 27 (TRIM27), TLR4/NF-κB pathway, pediatric pneumonia
Abstract
Background: Pneumonia widely occurs in children and has high global morbidity and mortality. There is an urgent requirement to clarify the underlying mechanism of pediatric pneumonia and definite its potential therapeutic targets. Tri-domain protein 27 (TRIM27) is one of the TRIM protein family members which widely participated in multiple cellular processes.
Objective: To assess whether TRIM27 protects against pediatric pneumonia.
Methods: A lipopolysaccharide (LPS)-induced inflammation injury model was constructed. The level of TRIM27 in LPS-induced cells was examined. The effects of TRIM27 in cell apoptosis and inflammatory response was evaluated. Moreover, the involvement of TLR4/NF-κB pathway were detected by Immunoblot.
Results: We established a lipopolysaccharide (LPS)-induced inflammation injury model. Our data confirmed that LPS-treated WI-38 cells demonstrated a down-regulated expression of TRIM27. Overexpression of TRIM27 effectively reduced apoptosis and up-regulated the inflammatory factors in LPS-treated WI-38 cells. Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway acted as a key point in LPS-mediated inflammation injuries, and overexpression of TRIM27 remarkably inhibited the activity of TLR4/NF-κB pathway, indicating the anti-inflammatory effect of TRIM27.
Conclusion: In conclusion, TRIM27 protects WI-38 cells against LPS-induced inflammation injuries by inhibiting TLR4/NF-κB pathway.
References
2. Shah SN, Bachur RG, Simel DL, Neuman MI. Does this child have pneumonia?: The rational clinical examination systematic review. JAMA. 2017;318(5):462–71. 10.1001/jama.2017.9039
3. de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet. 2020;396(10253):786–98.10.1016/S0140-6736(20)31550-6
4. Cao C, Chai Y, Shou S, Wang J, Huang Y, Ma T. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction. Int Immunopharmacol. 2018;54:169–76. 10.1016/j.intimp.2017.11.006
5. Knobloch J, Chikosi SJ, Yanik S, Rupp J, Jungck D, Koch A. A systemic defect in toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD. Am J Physiol Lung Cell Mol Physiol. 2016;310(1):L24–39. 10.1152/ajplung.00367.2014
6. Park JS, Park MY, Cho YJ, Lee JH, Yoo CG, Lee CT, et al. Anti-inflammatory effect of erdosteine in lipopolysaccharide-stimulated RAW 264.7 cells.Inflammation. 2016;39(4):1573–81. 10.1007/s10753-016-0393-4
7. Ma Y, Wei Z, Bast RC Jr., Wang Z, Li Y, Gao M, et al. Down-regulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo. Lab Invest. 2016;96(1):37–48. 10.1038/labinvest.2015.132
8. Zheng Q, Hou J, Zhou Y, Yang Y, Xie B, Cao X. Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res. 2015;25(10):1121–36. 10.1038/cr.2015.108
9. Zaman MM, Nomura T, Takagi T, Okamura T, Jin W, Shinagawa T, et al. Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2013;33(24):4971–84. 10.1128/MCB.00465-13
10. Jiang J, Xie C, Liu Y, Shi Q, Chen Y. Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27. Biomed Pharmacother. 2019;109:595–601. 10.1016/j.biopha.2018.10.148
11. Chen SY, Zhang HP, Li J, Shi JH, Tang HW, Zhang Y, et al. Tripartite motif-containing 27 attenuates liver ischemia/reperfusion injury by suppressing transforming growth factor beta-activated kinase 1 (TAK1) by TAK1 binding protein 2/3 degradation. Hepatology. 2021;73(2):738–58. 10.1002/hep.31295
12. Xing L, Tang X, Wu K, Huang X, Yi Y, Huan J. TRIM27 functions as a novel oncogene in non-triple-negative breast cancer by blocking cellular senescence through p21 ubiquitination. Mol Ther Nucleic Acids. 2020;22:910–23. 10.1016/j.omtn.2020.10.012
13. Zheng F, Xu N, Zhang Y. TRIM27 promotes hepatitis C virus replication by suppressing type I interferon response. Inflammation. 2019;42(4):1317–25. 10.1007/s10753-019-00992-5
14. Li XK, Xu XZ, Cong Q, Zhao F, Yang YY, Li AQ, et al. Tri-domain proteins 27 reduce inflammation and apoptosis in HK-2 cells and protect against acute kidney injury in mice. Eur Rev Med Pharmacol Sci. 2020;24(23):12258–66.
15. Chen EJ, Chen S, Zhou FL. Mechanism of TRIM27 promoting inflammatory response in lung cancer cells. Zhonghua Zhong Liu Za Zhi (Chinese J Oncol). 2021;43(10):1076–81.
16. Li Y, Meng Q, Wang L, Cui Y. TRIM27 protects against cardiac ischemia-reperfusion injury by suppression of apoptosis and inflammation via negatively regulating p53. Biochem Biophys Res Commun. 2021;557:127–34. 10.1016/j.bbrc.2021.03.061
17. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372(9):835–45. 10.1056/NEJMoa1405870
18. Nong W. Long non-coding RNA NEAT1/miR-193a-3p regulates LPS-induced apoptosis and inflammatory injury in WI-38 cells through TLR4/NF-kappaB signaling. Am J Transl Res. 2019;11(9):5944–55.
19. Zhang HX, Xu ZS, Lin H, Li M, Xia T, Cui K, et al. TRIM27 mediates STAT3 activation at retromer-positive structures to promote colitis and colitis-associated carcinogenesis. Nat Commun. 2018;9(1):3441. 10.1038/s41467-018-05796-z
20. Hao Y, Bai S, Peng J, Hong R, Ding J, Li Z, et al. TRIM27-mediated ubiquitination of PPAR gamma promotes glutamate-induced cell apoptosis and inflammation. Exp Cell Res. 2021;400(1):112437. 10.1016/j.yexcr.2020.112437
21. Ye R, Liu Z. ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway. Exp Mol Pathol. 2020;113:104350. 10.1016/j.yexmp.2019.104350
22. Yan J, Li J, Zhang L, Sun Y, Jiang J, Huang Y, et al. Nrf2 protects against acute lung injury and inflammation by modulating TLR4 and Akt signaling. Free Radic Biol Med. 2018;121:78–85. 10.1016/j.freeradbiomed.2018.04.557
23. Tang J, Xu L, Zeng Y, Gong F. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway. Int Immunopharmacol. 2021;91:107272. 10.1016/j.intimp.2020.107272
24. Liu Q, Zhang Y, Liu S, Liu Y, Yang X, Liu G, et al. Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca(2κ)-dependent PKC/p38MAPK/NF-kappaB pathway. J Neuroinflamm. 2019;16(1):10. 10.1186/s12974-019-1398-
25. Liu JX, Li X, Yan FG, Pan QJ, Yang C, Wu MY, et al. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-kappaB pathway. Int Immunopharmacol. 2019;66:336–46. 10.1016/j.intimp.2018.11.033
26. Wu F, Liu Y, Lv X, Miao X, Sun Y, Yu W. Small interference RNA targeting TLR4 gene effectively attenuates pulmonary inflammation in a rat model. J Biomed Biotechnol. 2012;2012:406435. 10.1155/2012/406435
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.